CNS Neuroscience & Therapeutics

译名:中枢神经系统神经科学与治疗学

SCIEJCR Q1中科院1区

5-10

2026

影响因子区间

平台估算

投稿周期

88%

2025

中国作者发文占比

3150 CHF

费用说明

收费

期刊简介:CNS Neuroscience & Therapeutics provides a medium for rapid publication of original clinical, experimental, and translational research papers, timely reviews and reports of novel findings of therapeutic relevance to the central nervous system, as well as papers related to clinical pharmacology, drug development and novel methodologies for drug evaluation. The journal focuses on neurological and psychiatric diseases such as stroke, Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, epilepsy, and drug abuse.

【译文】CNS Neuroscience & Therapeutics是一本提供快速发表原创临床、实验和转化研究论文、及时评论和与中枢神经系统治疗相关的发现报告以及与临床药理学、药物开发和药物评估新方法的论文的期刊。该期刊专注于中风、帕金森病、阿尔茨海默病、抑郁症、精神分裂症、癫痫和药物滥用等神经和精神疾病。

出版社
Wiley
语言
English
学科
医学
ISSN
1755-5930
eISSN
1755-5949
出版频率
季刊
创刊年份
2008
投稿网址
http://mc.manuscriptcentral.com/cnsdr
最近更新
2026-04-02 18:16:40
CNS Neuroscience & Therapeutics

指标当前值近三年趋势
JCR分区Q1
暂无
中科院分区1区
暂无
影响因子区间5-10
暂无